SoftOx Solutions AS
A clinical-stage pharmaceutical company developing non-toxic antimicrobial technology.
SOFTX | OL
Overview
Corporate Details
- ISIN(s):
- NO0010811961 (+2 more)
- LEI:
- 549300AETMWJS91G4A50
- Country:
- Norway
- Address:
- Martin Linges vei 25, 1364 Fornebu
- Website:
- https://soft-ox.com/
- Sector:
- Manufacturing
Description
SoftOx Solutions AS is a clinical-stage pharmaceutical company that has developed a patented, non-toxic antimicrobial technology. The technology is based on a stabilized formulation of hypochlorous acid (HOCl), an endogenous molecule used by the human immune system to combat pathogens. It is designed to be highly effective against a broad spectrum of bacteria, viruses, and fungi, and to eradicate and prevent biofilm infections. A key feature of the technology is that its mode of action does not induce antimicrobial resistance (AMR). The company's development pipeline focuses on significant health challenges, with a lead candidate, SoftOx Inhalation Solution (SIS), for treating airway infections, as well as other applications in wound care and disinfection.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-05 18:11 |
SoftOx Solutions AS: New Share Capital
|
English | 1.5 KB | ||
| 2025-11-28 14:32 |
SoftOx Solutions AS: Notice of Extraordinary General Assembly - Attachment: So…
|
English | 1.5 MB | ||
| 2025-11-28 14:32 |
SoftOx Solutions AS: Notice of Extraordinary General Assembly
|
English | 1.3 KB | ||
| 2025-11-28 14:31 |
SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility wi…
|
English | 3.2 KB | ||
| 2025-11-26 08:00 |
SoftOx Solutions AS: Third Quarter Report 2025 - Attachment: SoftOx Solutions_Q…
|
English | 983.3 KB | ||
| 2025-11-26 08:00 |
SoftOx Solutions AS: Third Quarter Report 2025
|
English | 334 bytes | ||
| 2025-11-14 08:35 |
SoftOx Solutions AS: GMP Drug Substance Successfully Manufactured – Key Milesto…
|
English | 2.9 KB | ||
| 2025-10-16 12:26 |
SoftOx Solutions AS: SoftOx submits Phase 1 Clinical Trial Application under th…
|
English | 2.2 KB | ||
| 2025-10-13 08:11 |
SoftOx Solutions AS: New Share Capital
|
English | 1.7 KB | ||
| 2025-10-07 21:17 |
SoftOx Solutions AS: Private Placement resolved
|
English | 3.0 KB | ||
| 2025-10-03 15:23 |
SoftOx Solutions AS: New Share Capital
|
English | 1.5 KB | ||
| 2025-10-01 14:35 |
SoftOx Solutions AS: Clinical Trial Application for Dose Escalation / Cystic Fi…
|
English | 2.6 KB | ||
| 2025-09-25 17:51 |
SoftOx Solutions AS: Clarification on Placement Commission
|
English | 1.5 KB | ||
| 2025-09-25 15:08 |
SoftOx Solutions AS: Private Placements resolved
|
English | 2.0 KB | ||
| 2025-09-23 09:07 |
SoftOx Solutions AS: SoftOx builds momentum: CF trial strategy reinforced by HO…
|
English | 3.6 MB |
Automate Your Workflow. Get a real-time feed of all SoftOx Solutions AS filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SoftOx Solutions AS
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SoftOx Solutions AS via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
